Positron emission tomography (PET) imaging is the most quantitative modality for assessing
disease activity at the molecular and cellular levels, and therefore, it allows monitoring its …

While not conventionally used as the first-line modality,[18 F]-2-fluoro-2-deoxy-D-glucose
(FDG)-positron emission tomography/computed tomography (PET/CT) can identify infection …

Purpose Without a standard test for pancreatic carcinomas, this highly lethal disease is
normally diagnosed at its advanced stage, leading to a low survival rate of patients …

Positron emission tomography (PET) imaging with 18F-fluorodeoxyglucose (FDG)
represents a method of detecting and characterizing arterial wall inflammation, with potential …

Traditional atherosclerosis imaging modalities are limited to late stages of disease, prior to
which patients are frequently asymptomatic. Positron emission tomography (PET) imaging …

Background Imaging evaluation of acute deep vein thrombosis (DVT) or post-thrombotic
syndrome (PTS) in animal or clinical models is limited to anatomical assessment of the …

Sarcoidosis is a systemic disease with unclear etiology characterized by the accumulation of
noncaseating, immune granulomas in affected tissues. In cardiac sarcoidosis (CS), white …

Purpose While radiotherapy (RT) for head and neck cancer (HNC) has made recent strides,
RT-induced vasculitis continues to adversely affect long-term patient outcomes. Guidelines …

Venous tumor thrombus is a rare complication of rectal cancer but is more common in other
types of cancer, like renal cell carcinoma and hepatocellular carcinoma. The usual site of …

Fluorodeoxyglucose (FDG)-PET plays an extensive role in modern personalized medicine.
FDG is taken up by cells via glucose transporters (GLUTs) and undergoes phosphorylation …